
NPC announces Takeda’s Jen Norton as board chair for 2025
NPC’s board also elected its Executive Committee for 2025.
NPC’s board also elected its Executive Committee for 2025.
Pricing and access to drugs and medical devices seen as the most significant issue facing the life sciences industry.
The Ohio Supreme Court held on a 5-2 vote that state law barred Lake and Trumbull counties' claims that pharmacy chains' dispensing of addictive pain medications created a public nuisance that the companies should be forced to remediate.
A recent analysis reveals that Medicare Part D plans increasingly restrict generic drugs to higher-cost tiers.
Bask Health's telehealth platform seamlessly connects patients to licensed providers specializing in GLP-1 medications like semaglutide and liraglutide.
The results underline the capabilities of the company's biosimilar platform and anticipated diversification of its portfolio.
The drive to make Food Is Medicine a mainstay of retailers’ role in health care is gaining momentum, according to the two trade associations most closely involved with the effort.
Strategy reflects Cencora’s commitment to meet customers’ evolving needs.
This collaboration integrates cutting-edge telemedicine technology into local pharmacies, enhancing access to primary and urgent care while reinforcing their critical role within communities.
The donation will help End Overdose distribute Padagis Naloxone to thousands of college students.
The groups say that bipartisan recognition of PBMs’ detrimental practices is widespread.
The agreement has been in place since 2019 and has scored a major new product launch success in delivering a biosimilar product into the Japanese market. This biosimilar is used with cancer medicines.
In 2024, fills for Wegovy and Zepbound increased by over 100% and 300%, respectively.
In-store clinics are central to the transition, according to the report, titled “The Healthcare Opportunity in Grocery.”
The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity.
The partnership addresses the growing need for sophisticated and robust robotic pharmacy automation systems in hospitals throughout North America.